[1]
“Stability indicating RP-HPLC method development and validation of cefepime and amikacin in pure and pharmaceutical dosage forms”, Braz. J. Pharm. Sci., vol. 54, no. 3, p. e17258, Nov. 2018, doi: 10.1590/s2175-97902018000317258.